// App-Quantinova.ai

175 : Circulating tumor cells as a possible marker for micrometastatic disease in patients with localized pancreatic cancer.

Researchers

Presenter

  • Rachel D. Aufforth

Principal Investigators

  • Justin J. Baker

  • Malgorzata A. Witek

  • Joyce W. Kamande

  • Hong Jin Kim

  • Pei-Fen Kuan

  • Steven A. Soper

  • Jen Jen Yeh

Medical Centers

  • University of North Carolina Department of Biomedical Engineering, Chapel Hill, NC

  • Maine Medical Center, Portland, ME

  • University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, NC

  • University of North Carolina School of Medicine, Division of Surgical Oncology and Endocrine Surgery, Chapel Hill, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Microphthalmia, syndromic, 9

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final